The Murcian was surprised by the inspired Canadian player, stubborn on service, and lost 3-6, 6-3, 6-3
Carlos Alcaraz fell this Friday in his debut as world number one against Canadian Félix Auger-Aliassime in the Davis Cup match between the two countries, which would decide the doubles match at stake at the end of this edition. The Canadian, 13th in the world, won 6-7 (3-7), 6-4, 6-2, after Roberto Bautista had previously overtaken Spain by beating Vasek Pospisil 3-6, 6-3, 6-3. defeat.
The world number one suffered against a very inspired and persistent Auger-Aliassime on serve – adding 16 ‘aces’ throughout the match – and won the match after 2 hours and 50 minutes of play. Alcaraz, who has had barely three days since his arrival on Tuesday from the United States, where he won the US Open on Sunday, finally pulled hard to keep up with the Canadian and take the first set to a tiebreak. In sudden death, the mistakes the Canadian had not made in the previous twelve games appeared, leaving the Spaniards victorious 7-3.
In the second set, the Canadian broke his opponent’s serve to lead 5-4 and serve to take the set. The match went to the third and final set, where Auger-Aliassime, with two consecutive breaks, put the game on track.
Earlier, Bautista (#21) defeated Vasek Pospisil 3-6, 6-3, 6-3. Pospisil (No. 141) started strong and went over Bautista in the first set, supported by his serve, short runs and deadly net climbs. Bautista reacted in the second and took a 3-0 lead, eventually taking the set. The final lap started right away, but physical discomfort that required Pospisil to be treated paved the way for Bautista. The Canadian was able to save three match points, but was unable to avoid the fourth.
Source: La Verdad
I’m an experienced news author and editor based in New York City. I specialize in covering healthcare news stories for Today Times Live, helping to keep readers informed on the latest developments related to the industry. I have a deep understanding of medical topics, including emerging treatments and drugs, the changing laws that regulate healthcare providers, and other matters that affect public health.
